Feed A7RU.SI
A7

Keppel Infrastructure Trust A7RU.SI · SES

$0.49 +0.00% (+$0.00)

Summary

51 / 100 · Bulios Score

What speaks for it

  • Earnings per share grew by 325% a year over the last 3 years.
  • The share price is below the Bulios Fair Price.
  • Out of every 100 SGD of revenue, 6.9 SGD is left as free cash.

What to watch

  • It pays out more in dividends than it earns: 264% of profit.
  • Repaying its net debt would take 5.7 years of operating profit.
  • Revenue growth is slowing: 4.3% a year over the last 3 years against 8.7% over 5 years.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $0.49
5-year average P/E 47.8 32% lower
P/E today 32.6
Chemicals - Specialty industry median
P/E today 32.6

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 32.6 SGD for 1 SGD of yearly profit. Over the last five years it was 47.8 SGD on average.

Valuation in detail

Is it growing?

Slowly

Revenue (SGD)

Diluted EPS (SGD)

  • Analyst estimate

Revenue grew by 8.7% a year over 5 years. Over the last 3 years it grew by 4.3% a year. Earnings per share grew by 325% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 SGD of revenue goes

Net profit, industry median (Chemicals - Specialty) 6.1 SGD

Out of every 100 SGD of revenue, 3.6 SGD is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Repaying all its debt would take 20.1 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

High, at risk
Yield
8.08%
Paid out of profit
264%
Raised in a row
1 year

You receive $0.04 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.